Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BLISS Tincture is a doctor-backed, cannabis-based Ayurvedic prescription tincture developed by BOHECO (Bombay Hemp Company) for the management of anxiety, stress, and mental restlessness. The formulation contains 45 mg/ml of broad-spectrum cannabidiol (CBD) derived from cannabis leaf extract, which acts on the endocannabinoid system via the cannabinoid receptors CB1 and CB2 to promote calm and emotional balance without causing euphoria or sedation. It is further enriched with traditional Ayurvedic adaptogens, including Ashwagandha (Withania somnifera), Brahmi (Bacopa monnieri), and Tulsi (Ocimum sanctum), which help regulate cortisol levels and support stress resilience.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BLISS Tincture.